T0	Interventions 76 157	Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab
T1	Interventions 165 235	Paclitaxel-Carboplatin-Bevacizumab Followed byÂ Maintenance Bevacizumab
T2	Interventions 466 550	(pemetrexed-carboplatin-bevacizumab and maintenance pemetrexed-bevacizumab [PemCBev]
T3	Interventions 553 554	.
T4	Interventions 555 628	paclitaxel-carboplatin-bevacizumab and maintenance bevacizumab [PacCBev])
T5	Interventions 897 909	for PemCBev;
T6	Interventions 918 932	versus PacCBev